Viewing StudyNCT00001044



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00001044
Status: COMPLETED
Last Update Posted: 2021-11-04
First Post: 1999-11-02

Brief Title: A Phase I Multicenter Randomized Double-Blind Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120HIV-1MN Genentech in Combination With QS21 Adjuvant andor Alum in Healthy Adults
Sponsor:
Organization: National Institute of Allergy and Infectious Diseases NIAID